À retenir
In a 50-patient pilot trial of remote cardiac rehabilitation with a Fitbit, peak oxygen consumption rose from baseline in both the coached group (+1.6 mL/kg/min, P<.001) and the wearable-only group (+0.6 mL/kg/min, P=.008), with no difference between groups (P=.65). The trial was small, single-center and open-label, so it cannot show that coaching improves fitness.
Study design
Essai randomisé
Reading basis
Published abstract
Reading focus
Comparator & uncertainty
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Cardiac rehabilitation helps prevent heart disease, but many patients cannot attend programs. The authors tested whether a remote program based on a wearable and real-time monitoring improves exercise capacity in people with coronary artery disease (CAD), and whether adding weekly online coaching (OLC) improves results further.
Population et méthode
Randomized, open-label, single-center pilot trial (phase III) of 50 patients with CAD. After baseline cardiopulmonary exercise tests (CPETs), everyone received a CPET-based home exercise program, a Fitbit Sense and a real-time monitoring system (Recoval). Patients were randomly assigned to wearable plus online coaching (n=25) or wearable only (CON, n=25). The primary outcomes were changes in peak oxygen consumption (peak VO2) and anaerobic threshold VO2 at 12 weeks; secondary outcomes were other CPET measures, daily activity, anxiety and health-related quality of life.
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Peak VO2 rose from baseline to 12 weeks in both groups: +1.6 mL/kg/min (P<.001) with coaching and +0.6 mL/kg/min (P=.008) without; the difference between groups was not significant (P=.65).
- 2Anaerobic threshold VO2 also rose in both groups: +1.0 mL/kg/min (P=.001) with coaching and +1.3 mL/kg/min (P=.002) without, with no between-group difference (P=.90).
- 3In the latter half of the program, daily distance and highly active time were significantly higher in the coached group (all P<.05).
- 4Mental status and health-related quality of life did not differ between groups. No major adverse cardiac events were reported, and one coached patient dropped out because of lower limb muscle strain.
Limites et incertitude
- 1With 25 patients per group, the pilot was not large enough to detect modest differences between the arms, and the null between-group results may reflect low power.
- 2There was no group without a wearable or remote program, so the fitness gains in both groups cannot be attributed to the technology itself.
- 3Open-label, single-center design and 12 weeks of follow-up mean the findings may not apply to other hospitals, populations or longer-term outcomes; the authors ask for more diverse populations and longer periods.
- 4The activity increase in the coached group came from device-recorded data in the later weeks only, and this reading is based on the abstract only.
Mise en perspective
For people with stable coronary artery disease who cannot attend a center, a home program using a wearable and remote monitoring appears feasible and was linked to better exercise capacity in this small trial, but coaching did not clearly add fitness. Remote rehab should be arranged with your cardiology team, who set safe exercise intensity.
Vos données
Daily distance, active minutes and heart rate during exercise from a wearable are what this program monitored. Use the same device and similar routes, and focus on trends over weeks. Peak VO2 was measured in a clinic test, and a watch's VO2max estimate is not the same thing.
Comprendre ce type de preuve
Randomisation can support causal inference, but check allocation, blinding, missing outcomes, follow-up and the actual comparator. A trial label alone does not establish high certainty.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Background
Cardiac rehabilitation (CR) is effective in preventing cardiovascular diseases; however, participation in CR programs remains limited due to the associated challenges. The integration of wearable devices and real-time monitoring offers a potential solution to enhance adherence to remote CR programs and their outcomes.
Objective
This study aimed to evaluate the efficacy of a remote CR program using wearable devices and real-time monitoring with or without online coaching (OLC) in improving exercise capacity in patients with coronary artery disease (CAD).
Methods
We enrolled 50 patients with CAD in a remote CR program in this randomized, open-label, single-center pilot trial (phase III). After baseline cardiopulmonary exercise tests (CPETs), all patients were assigned a CPET-based home exercise program and were provided with a wearable device (Fitbit Sense; Fitbit, Inc) with a real-time monitoring system (Recoval; SapplyM, Inc). The patients were randomly assigned to an intervention group with OLC (n=25) or a control wearable device (CON; n=25) group. The primary outcomes were changes in peak oxygen consumption (peak VO2) and anaerobic threshold VO2 (oxygen consumption) at 12 weeks. The secondary outcomes were changes in CPET parameters, daily activity, anxiety levels, and health-related quality of life.
Results
Peak VO2 and anaerobic threshold VO2 increased significantly from baseline to 12 weeks in the OLC (+1.6 mL/kg/min, P<.001; +1.0 mL/kg/min, P=.001) and CON (+0.6 mL/kg/min, P=.008; +1.3 mL/kg/min, P=.002) groups with no significant between-group differences (P=.65 and P=.90). In the latter half of the intervention, the daily distance and highly active time in the OLC group were significantly increased compared with those in the CON group (all P<.05). Mental status and health-related quality of life scores showed no significant differences between the groups. No major adverse cardiac events were reported. One patient in the OLC group dropped out due to lower limb muscle strain.
Conclusions
Remote CR using wearable devices and a real-time monitoring system significantly improved exercise capacity in patients with CAD over a 12-week intervention program. The addition of regular OLC to the intervention program further enhanced the physical activity levels, particularly in high-intensity activities. Future studies are warranted to validate these findings in more diverse populations and over longer intervention periods to optimize the benefits and safety of remote CR programs.
Sources et attribution
Wearable Devices in Remote Cardiac Rehabilitation With and Without Weekly Online Coaching for Patients With Coronary Artery Disease: Randomized Controlled Trial.
Nishio R, Dohi T, Yokoyama M, Nakade T, Takahashi N, Chikata Y, Endo H, Nishiyama H, Okai I, Iwata H, Okazaki S, Miyauchi K, Daida H, Minamino T.
JMIR mHealth and uHealth · 2025-05-12
DOI: 10.2196/63797 ↗PubMed · 40395066 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
Activity–stroke and heart attack curves differ by accelerometer processing method
Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.
Preventive Medicine
Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven
A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.
Forensic Science International
Activity trackers: about 1,800 more steps a day, but small effects on other outcomes
An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.
The Lancet Digital Health
Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages
In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.
Sleep

